Dr Hatton, a Qualified Person (QP) with a PhD in Organic Chemistry, joins as Head of Quality Control following a period of self-employment during which he delivered training courses for Pharmaceutical Training International on Good Manufacturing Practice (GMP) topics and carried out a pilot study with AstraZeneca on Strategy for the Global Quality Department. Dr Hatton began his career with Smithkline Beecham progressing through the organisation as Analytical Development Manager then Quality Assurance Manager prior to becoming head of the Global Analytical Sciences Department and finally reporting to the Board as Project Manager Manufacturing Regulatory Documents. Dr Hatton then spent 5 years with Bovis Lend Lease Pharmaceutical as Compliance Manager/Principal Quality Consultant before joining Acuma Solutions as Life Sciences Consultant. Martin Price joins as HSE Manager with responsibility for managing compliance with Health & Safety and Environmental requirements. Accredited by the Institute of Occupational Safety & Health, Martin has extensive and wide-ranging experience in general manufacturing having worked as an Engineering / HSE Manager at Panasonic, Musashi Auto Parts and as a lecturer and programme manager at Neath College. Peter George, CEO of Penn Pharmaceuticals commented: "These appointments are a real boost for Penn. Both bring impressive technical and commercial expertise and experience to the company and I am confident they will make a hugely valuable contribution to our ambitious plans for the development of the company. "Demand for the outsourcing of manufacturing, pharmaceutical development and clinical support is growing. Penn combines high quality technical expertise with a company size and culture that allows great customer focus," he said. Penn is a leading provider of fully integrated and cost effective pharmaceutical development and custom manufacturing services to the international health care industry, whose services support a fast and effective route from drug discovery to market. Penn provides unparalleled service offerings, developed over its 30 year trading history, which are individually excellent and compelling in combination. Penn’s Services include formulation and analytical development, clinical trial manufacturing, packing, storage and supply management, specialised custom manufacturing, CMC consultancy and QP services. Penn has global reach through an international sales force and strategic alliances for its services offered from its single site operation in South Wales. Penn operates quality systems, proven through audit and compliance with GMP. Penn is licensed by MHRA for manufacturing, dealing and import and FDA with whom Penn is registered for certain drug product manufacture and assembly of medical devices. Penn is licensed by the UK Home Office for controlled drugs.